Jones Day has advised BioMarin Pharmaceutical Inc. in the acquisition of Amicus Therapeutics. Kirkland & Ellis has advised Amicus Therapeutics. BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has...
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion
CoreWeave’s $2.3 Billion Debt Financing Facility
Kirkland & Ellis advised CoreWeave on the deal. CoreWeave announced it secured $2.3 billion debt financing facility. The funding was led by Magnetar Capital and funds managed...


























